BCM
SVNT

Bridgeway Capital Management’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Bridgeway Capital Management’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-186,748
Closed -$117K – 1514
2013
Q3 		$117K Sell
186,748
-65,152
-26% -$41.7K ﹤0.01% 1367
2013
Q2 		$141K Buy
+251,900
New +$175K 0.01% 1319

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $182M AUM 26.44% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bridgeway Capital Management's SVNT Position: Q4 2013 in Review

Bridgeway Capital Management sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 186,748 shares — an estimated $117K sold.

Bridgeway Capital Management first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $141K in Q2 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Bridgeway Capital Management reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Bridgeway Capital Management sold 186,748 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $117K.
  • Bridgeway Capital Management first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Bridgeway Capital Management's SAVIENT PHARMACEUTICALS INC position peaked at $141K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Bridgeway Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.